✦ LIBER ✦
Phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage IIb, III or IV non-small cell lung cancer unsuitable for radical therapy
✍ Scribed by Gwyn Bebb; Colum Smith; Stewart Rorke; William Boland; Leonardo Nicacio; Ryan Sukhoo; Anthony Brade
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 422 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.